175 related articles for article (PubMed ID: 37189445)
1. Mutational Analysis of Anesthetic Binding Sites and Their Effects on GABA
Pierce SR; Germann AL; Xu SQ; Menon SL; Ortells MO; Arias HR; Akk G
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189445
[TBL] [Abstract][Full Text] [Related]
2. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the mammalian GABA
Arias HR; Germann AL; Pierce SR; Sakamoto S; Ortells MO; Hamachi I; Akk G
Br J Pharmacol; 2022 Dec; 179(24):5323-5337. PubMed ID: 36082615
[TBL] [Abstract][Full Text] [Related]
4. Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content.
Arias HR; Ravazzini F; Targowska-Duda KM; Kaczor AA; Feuerbach D; Boffi JC; Draczkowski P; Montag D; Brown BM; Elgoyhen AB; Jozwiak K; Puia G
Int J Biochem Cell Biol; 2016 Jul; 76():19-30. PubMed ID: 27129924
[TBL] [Abstract][Full Text] [Related]
5. Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation.
Targowska-Duda KM; Budzynska B; Michalak A; Wnorowski A; Loland CJ; Maj M; Manetti D; Romanelli MN; Jozwiak K; Biala G; Arias HR
Eur Neuropsychopharmacol; 2021 Nov; 52():31-47. PubMed ID: 34237657
[TBL] [Abstract][Full Text] [Related]
6. Allosteric Agonism of
Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
[TBL] [Abstract][Full Text] [Related]
7. Chemical, Pharmacological, and Structural Characterization of Novel Acrylamide-Derived Modulators of the GABA
Arias HR; Pierce SR; Germann AL; Xu SQ; Ortells MO; Sakamoto S; Manetti D; Romanelli MN; Hamachi I; Akk G
Mol Pharmacol; 2023 Sep; 104(3):115-131. PubMed ID: 37316350
[TBL] [Abstract][Full Text] [Related]
8. Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.
Chiara DC; Jayakar SS; Zhou X; Zhang X; Savechenkov PY; Bruzik KS; Miller KW; Cohen JB
J Biol Chem; 2013 Jul; 288(27):19343-57. PubMed ID: 23677991
[TBL] [Abstract][Full Text] [Related]
9. Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant
Stokes C; Garai S; Kulkarni AR; Cantwell LN; Noviello CM; Hibbs RE; Horenstein NA; Abboud KA; Thakur GA; Papke RL
J Pharmacol Exp Ther; 2019 Aug; 370(2):252-268. PubMed ID: 31175218
[TBL] [Abstract][Full Text] [Related]
10. Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses.
Sanders VR; Millar NS
Pharmacol Res; 2023 May; 191():106759. PubMed ID: 37023990
[TBL] [Abstract][Full Text] [Related]
11. 3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of α7 nicotinic receptors, produces anxiolytic-like activity in mice.
Targowska-Duda KM; Budzynska B; Michalak A; Jozwiak K; Biala G; Arias HR
J Psychopharmacol; 2019 May; 33(5):558-567. PubMed ID: 30644335
[TBL] [Abstract][Full Text] [Related]
12. The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in Mice.
Bagdas D; Targowska-Duda KM; López JJ; Perez EG; Arias HR; Damaj MI
Anesth Analg; 2015 Nov; 121(5):1369-77. PubMed ID: 26280585
[TBL] [Abstract][Full Text] [Related]
13. The influence of allosteric modulators and transmembrane mutations on desensitisation and activation of α7 nicotinic acetylcholine receptors.
Chatzidaki A; D'Oyley JM; Gill-Thind JK; Sheppard TD; Millar NS
Neuropharmacology; 2015 Oct; 97():75-85. PubMed ID: 25998276
[TBL] [Abstract][Full Text] [Related]
14. Positive and Negative Allosteric Modulation of an α1β3γ2 γ-Aminobutyric Acid Type A (GABAA) Receptor by Binding to a Site in the Transmembrane Domain at the γ+-β- Interface.
Jayakar SS; Zhou X; Savechenkov PY; Chiara DC; Desai R; Bruzik KS; Miller KW; Cohen JB
J Biol Chem; 2015 Sep; 290(38):23432-46. PubMed ID: 26229099
[TBL] [Abstract][Full Text] [Related]
15. Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
Collins T; Young GT; Millar NS
Neuropharmacology; 2011 Dec; 61(8):1306-13. PubMed ID: 21820451
[TBL] [Abstract][Full Text] [Related]
16. The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice.
Targowska-Duda KM; Wnorowski A; Budzynska B; Jozwiak K; Biala G; Arias HR
Behav Brain Res; 2016 Apr; 302():142-51. PubMed ID: 26778787
[TBL] [Abstract][Full Text] [Related]
17. (
Arias HR; Ghelardini C; Lucarini E; Tae HS; Yousuf A; Marcovich I; Manetti D; Romanelli MN; Elgoyhen AB; Adams DJ; Di Cesare Mannelli L
ACS Chem Neurosci; 2020 Nov; 11(21):3603-3614. PubMed ID: 33073974
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor.
Targowska-Duda KM; Feuerbach D; Biala G; Jozwiak K; Arias HR
Neurosci Lett; 2014 May; 569():126-30. PubMed ID: 24708923
[TBL] [Abstract][Full Text] [Related]
19. The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.
Papke RL; Horenstein NA; Kulkarni AR; Stokes C; Corrie LW; Maeng CY; Thakur GA
J Biol Chem; 2014 Feb; 289(7):4515-31. PubMed ID: 24362025
[TBL] [Abstract][Full Text] [Related]
20. ELIC-α7 Nicotinic acetylcholine receptor (α7nAChR) chimeras reveal a prominent role of the extracellular-transmembrane domain interface in allosteric modulation.
Tillman TS; Seyoum E; Mowrey DD; Xu Y; Tang P
J Biol Chem; 2014 May; 289(20):13851-7. PubMed ID: 24695730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
